HINJ President and CEO Chrissy Buteas Interviewed by Steve Adubato on State of Affairs Show
HINJ President and CEO Chrissy Buteas was recently interviewed by Steve Adubato on his State of Affairs show to discuss New Jersey’s life sciences and our contributions to global human health and our state’s workforce and economy. The interview can be found here.
Op-Ed: Protect Future Cures While Lowering Cost of Health Care
An op-ed by Chrissy Buteas, HINJ President and Chief Executive Officer. New Prescription Drug Affordability Council must take a balanced approach that helps patients without harming potential cures The cost of health care is a critical issue — for patients, for families and loved ones, and for businesses and governments. It can often mean the […]
Op Ed/Editorial Response: “New Jersey’s Life Sciences Might Have Saved Your Grandmother’s Life”
by Chrissy Buteas, President and Chief Executive OfficerHealthCare Institute of New Jersey (HINJ) Trenton, October 31, 2024 ― I write in response to your editorial published on October 27. The piece was unfortunate in its significant misrepresentation and vastly oversimplified portrayal of one of the most transformative and life-saving industries in human history – the […]
HealthCare Institute of New Jersey Statement on Assembly Bill A-4953, the Patient and Provider Protection Act
Trenton, October 24, 2024 ― Chrissy Buteas, President and Chief Executive Officer of the HealthCare Institute of New Jersey, released the following statement concerning Assembly Bill A-4953, the Patient and Provider Protection Act: “The House Energy and Commerce Committee, the Federal Trade Commission (FTC), the Wall Street Journal and the New York Times have all […]
HealthCare Institute of New Jersey Statement on the Senate Legislative Oversight Committee’s AI Hearing
Trenton, October 21, 2024 ― Chrissy Buteas, President and Chief Executive Officer of the HealthCare Institute of New Jersey, released the following statement concerning today’s Senate Legislative Oversight Committee Hearing entitled, “How artificial intelligence (AI) is defined and the AI landscape in New Jersey.” “New Jersey and our state’s innovation ecosystem are at the forefront […]
HealthCare Institute of New Jersey Statement on the Prescription Drug Affordability Council
Trenton, October 11, 2024 ― Chrissy Buteas, President and Chief Executive Officer of the HealthCare Institute of New Jersey, released the following statement concerning the State’s recent completion of appointments to the Prescription Drug Affordability Council (PDAC): “Drug development is an extraordinarily complex and multifaceted journey, with middlemen in the supply chain – such as […]
HealthCare Institute of New Jersey Statement on the Federal Trade Commission’s Final HSR Premerger Notification Rules
Trenton, October 11, 2024 ― The HealthCare Institute of New Jersey released the following statement concerning the Federal Trade Commission’s (FTC) final Hart-Scott-Rodino (HSR) premerger notification rules issued yesterday: “The final HSR rules as issued by the Federal Trade Commission will impose a significant burden on the future of New Jersey’s life sciences community and our […]
New Jersey’s Cutting-Edge Medical Technology Sector Saves Lives Around the World
By Chrissy Buteas, President and Chief Executive Officer HealthCare Institute of New Jersey (HINJ) Published September 24, 2024 New Jersey, long hailed as the “Medicine Chest of the World,” boasts a thriving life sciences community and is a beacon of global medical innovation. It’s a source of pride that the treatments and cures saving lives worldwide […]
HealthCare Institute of New Jersey Statement on the Federal Trade Commission’s Action Against Pharmacy Benefit Managers
Trenton, September 20, 2024 ― The HealthCare Institute of New Jersey (HINJ – www.hinj.org), released the following statement concerning the Federal Trade Commission’s (FTC) legal action against the three largest pharmacy benefit managers (PBMs): “HINJ applauds the FTC’s lawsuit filed today against PBMs for their anticompetitive and unfair practices that harm patients by artificially increasing […]
HINJ is Hiring!
Trenton, September 3, 2024 ― We are excited to announce an opening for the position of Director of Government and External Relations. This pivotal role will represent HINJ before government officials and engage stakeholders to build support of public policies that protect patient access and innovation and highlight and promote the value New Jersey’s life […]